ADRs End Higher; Biophytis Climbs 30%
This article was automatically generated by Dow Jones Newswires using technology from Automated Insights.
International stocks trading in New York closed higher on Tuesday, as the S&P/BNY Mellon index of American depositary receipts gained 0.4% to 179.79.
The European index fell 0.1% to 173.27. The Asian index gained 1.1% to 211.35. The Latin American index increased 0.6% to 218.61, while the emerging-markets index rose 1.4% to 338.74.
France's Biophytis was the biggest leader during the session, soared 30% to 42 cents, and Switzerland-based Addex Therapeutics soared 28% to $27.90. Niu Technologies, which is based in China, rounded out the top three leaders on Tuesday, with shares gained 26% to $2.27.
Eco Wave Power Global, based in Sweden, posted the largest decline, cratered 28% to $3.01, followed by shares of Hong Kong's Lion Group Holding, which tumbled 12% to 70 cents. Shares of China-based Adlai Nortye tumbled 12% to $10.80.
Data source: Dow Jones Market Data, FactSet.
(END) Dow Jones Newswires
April 09, 2024 16:54 ET (20:54 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?